Enimmune Corporation (TPEX:6564)
16.50
+0.40 (2.48%)
Aug 26, 2026, 1:47 PM CST
-1.49% (1Y)
| Market Cap | 1.16B -3.9% |
| Revenue (ttm) | 53.45M +26.6% |
| Net Income | -120.88M |
| EPS | -1.68 |
| Shares Out | 72.13M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 96,789 |
| Open | 16.25 |
| Previous Close | 16.10 |
| Day's Range | 16.20 - 16.85 |
| 52-Week Range | 14.90 - 23.90 |
| Beta | 0.25 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 25, 2026 |